Product Theater and Lunch Learn More: An oral Treatment Option for Adults with Schizophrenia or Bipolar I Disorder Supported by Alkermes
Registration Options
Activity Date: 04/25/2022
AAPP 2022 registration is closed.
Session Time and Location
The live session is complete.
Session Summary
The presentation will begin after in-person meals are served (an estimated 15-30 minute delay). Thank you for your patience.
This program will provide an overview of the clinical data, information for use in clinical practice, and important safety information supporting an oral treatment option for adult patients living with schizophrenia or bipolar I disorder.
Dr. Hanaie holds a Bachelor of Science degree from the University of California, Los Angeles, with a major in Psychobiology and a minor in Education. He attended USC, where he earned a Doctorate of Pharmacy Degree in 2007; and since he has become certified and board licensed as an Advanced Practice Pharmacist. He has continued his involvement with the University of Southern California as both a precepting and adjunctive faculty, as well as a teaching professor at other Medical and Pharmacy schools in California.
Dr. Hanaie is the cofounder of an organization called Miracles in the Making (MITM); a nonprofit organization founded in 2001 dedicated to fundraising and spending quality time with needy children at various orphan homes. He is currently serving as the Chief Director of Pharmacy and the Distinguished Chair of the Pharmacy and Therapeutics committee at Kedren Hospital, one of the largest Mental Health facilities in California.
Faculty Disclosures
Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
System Update:
We are undergoing major upgrades right now, and we appreciate your patience.
If you need help, please use the support chat or email info@aapp.org.
Learn more.
